Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma.
暂无分享,去创建一个
L. Gordon | J. Murray | T. Witzig | G. Wiseman | C. Emmanouilides | P. Multani | C. White | J. Lister
暂无分享,去创建一个
L. Gordon | J. Murray | T. Witzig | G. Wiseman | C. Emmanouilides | P. Multani | C. White | J. Lister